Radiopathomics: Integration of radiographic and histologic characteristics for prognostication in glioblastoma

  title={Radiopathomics: Integration of radiographic and histologic characteristics for prognostication in glioblastoma},
  author={Saima Rathore and Muhammad Aksam Iftikhar and Metin Nafi G{\"u}rcan and Zissimos P. Mourelatos},
Large number of diverse imaging [e.g., multi-parametric MRI (mpMRI), and digital pathology images] and non-imaging (e.g., clinical) biomedical data streams are being routinely acquired as part of the standard clinical workflow for glioblastoma patients. However, under the current clinical practice, these data streams are not collectively used for diagnosis. We sought to assess the synergies between pathologic, and radiomic features by evaluating the predictive value of each group of… Expand
3 Citations
Glioma Grading via Analysis of Digital Pathology Images Using Machine Learning
The findings suggest that the texture features, when combined with conventional imaging and clinical markers, may provide an objective, accurate, and integrated prediction of glioma grades. Expand
Current Status of the Use of Machine Learning and Magnetic Resonance Imaging in the Field of Neuro-Radiomics
An overview of various MRI imaging sequences, such as contrast-enhanced, dynamic susceptibility contrast, diffusion tensor imaging, and conventional MRI, used in routine clinical settings, and the current status of the use of machine learning on MRI scans are provided. Expand
Radiomics at a Glance: A Few Lessons Learned from Learning Approaches
A perspective reviews some selected learning methods by focusing on both their significance for radiomics and their unveiled potential, as well as focusing on especially deep learning that stands out as the leading inference approach. Expand


Prediction of overall survival and molecular markers in gliomas via analysis of digital pathology images using deep learning
A computational approach based on deep learning to predict the overall survival and molecular subtypes of glioma patients from microscopic images of tissue biopsies, reflecting measures of microvascular proliferation, mitotic activity, nuclear atypia, and the presence of necrosis is developed. Expand
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1
Three distinct and reproducible imaging subtypes of glioblastoma are discovered, with differential clinical outcome and underlying molecular characteristics, including isocitrate dehydrogenase-1 (IDH1), O6-methylguanine–DNA methyltransferase, epidermal growth factor receptor variant III (EGFRvIII), and transcriptomic subtype composition, which point to the need for precision diagnostics and personalized treatment. Expand
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
The genome-wide architecture of intratumor variability in GB is revealed across multiple spatial scales and patient-specific patterns of cancer evolution, with consequences for treatment design. Expand
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
The set-up and results of the Multimodal Brain Tumor Image Segmentation Benchmark (BRATS) organized in conjunction with the MICCAI 2012 and 2013 conferences are reported, finding that different algorithms worked best for different sub-regions, but that no single algorithm ranked in the top for all sub-Regions simultaneously. Expand
Predicting cancer outcomes from histology and genomics using convolutional networks
This study illustrates how this approach can integrate information from both histology images and genomic biomarkers to predict time-to-event patient outcomes, and demonstrates performance surpassing the current clinical paradigm for predicting the survival of patients diagnosed with glioma. Expand
Imaging in neuro-oncology
This review aims to provide an overview of several advanced imaging modalities including magnetic resonance imaging and positron emission tomography, including advances in new PET agents, and summarize several key areas of their applications, including improving the accuracy of diagnosis and addressing the challenging clinical problems. Expand
Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
Machine learning analysis of DTI texture information and tumor size reliably predicts IDH status in preoperative MRI of gliomas, underlining the joint contribution of imaging data to classification. Expand
The Somatic Genomic Landscape of Glioblastoma
Correlative analyses confirm that the survival advantage of the proneural subtype is conferred by the G-CIMP phenotype, and MGMT DNA methylation may be a predictive biomarker for treatment response only in classical subtype GBM. Expand
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
A robust gene expression-based molecular classification of GBM into Proneural, Neural, Classical, and Mesenchymal subtypes is described and multidimensional genomic data is integrated to establish patterns of somatic mutations and DNA copy number. Expand
Glioblastoma survival in the United States before and during the temozolomide era
The survival of patients with newly diagnosed glioblastoma improved from 2000–2003 to 2005–2008, likely due to temozolomide use, but median survival time after gliOBlastoma diagnosis in the SEER population remains well under one year, largely driven by poor prognosis in elderly patients. Expand